These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33827302)

  • 21. Identification and characterization of stress degradation products of febuxostat employing ultra-performance liquid chromatography-ultraviolet/photodiode array and liquid chromatography-mass spectrometry/time-of-flight studies.
    Saha M; Bali A; Patra SR; Singh J
    Rapid Commun Mass Spectrom; 2023 Jan; 37(2):e9423. PubMed ID: 36278931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liquid chromatography electrospray ionization tandem mass spectrometry study of nilutamide and its stress degradation products: in silico toxicity prediction of degradation products.
    Ramesh Babu A; Borkar RM; Raju G; Raju B; Srinivas R
    Biomed Chromatogr; 2014 Jun; 28(6):788-93. PubMed ID: 24861745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of degradation products of ivabradine by LC-HR-MS/MS: a typical case of exhibition of different degradation behaviour in HCl and H2SO4 acid hydrolysis.
    Patel PN; Borkar RM; Kalariya PD; Gangwal RP; Sangamwar AT; Samanthula G; Ragampeta S
    J Mass Spectrom; 2015 Feb; 50(2):344-53. PubMed ID: 25800016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and characterization of urapidil stress degradation products by LC-Q-TOF-MS and NMR: Toxicity prediction of degradation products.
    Velip L; Dhiman V; Kushwah BS; Golla VM; Gananadhamu S
    J Pharm Biomed Anal; 2022 Mar; 211():114612. PubMed ID: 35101803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study on forced degradation behaviour of dofetilide by LC-PDA and Q-TOF/MS/MS: Mechanistic explanations of hydrolytic, oxidative and photocatalytic rearrangement of degradation products.
    Thalluri B; Dhiman V; Tiwari S; Baira SM; Kumar Talluri MVN
    J Pharm Biomed Anal; 2020 Feb; 179():112985. PubMed ID: 31780282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Separation and characterization of related substances of Lurasidone hydrochloride by LC-QTOF-MS techniques.
    Siddig O; Liu C; Abdulbagi M; Song M; Lu YT; Hang TJ
    J Pharm Biomed Anal; 2024 Jan; 238():115834. PubMed ID: 37948773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and characterization of stressed degradation products of prulifloxacin using LC-ESI-MS/Q-TOF, MSn experiments: development of a validated specific stability-indicating LC-MS method.
    Raju B; Ramesh M; Srinivas R; Raju SS; Venkateswarlu Y
    J Pharm Biomed Anal; 2011 Nov; 56(3):560-8. PubMed ID: 21783336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validated stability indicating assay method of olaparib: LC-ESI-Q-TOF-MS/MS and NMR studies for characterization of its new hydrolytic and oxidative forced degradation products.
    Thummar M; Kuswah BS; Samanthula G; Bulbake U; Gour J; Khan W
    J Pharm Biomed Anal; 2018 Oct; 160():89-98. PubMed ID: 30075398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and characterization of stress degradation products of dronedarone hydrochloride employing LC-UV/PDA, LC-MS/TOF and MS(n) studies.
    Chadha R; Bali A; Bansal G
    J Pharm Biomed Anal; 2016 Jan; 118():139-148. PubMed ID: 26547261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of degradation behavior of besifloxacin, characterization of its degradation products by LC-ESI-QTOF-MS and their in silico toxicity prediction.
    Salunke N; Kharkar PS; Pandita N
    Biomed Chromatogr; 2019 Jun; 33(6):e4489. PubMed ID: 30652327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of forced degradation products of ketorolac tromethamine using LC/ESI/Q/TOF/MS/MS and in silico toxicity prediction.
    Kalariya PD; Raju B; Borkar RM; Namdev D; Gananadhamu S; Nandekar PP; Sangamwar AT; Srinivas R
    J Mass Spectrom; 2014 May; 49(5):380-91. PubMed ID: 24809899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural identification of degradants of moexipril by LC-MS/MS.
    Challa PR; K R; K M V NR
    Biomed Chromatogr; 2017 Nov; 31(11):. PubMed ID: 28493358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of forced degradation products of tedizolid phosphate by liquid chromatography/electrospray ionization tandem mass spectrometry.
    Lei Y; Jin B; Ma C; Zhang T; Li T
    J Pharm Biomed Anal; 2017 May; 139():221-231. PubMed ID: 28292681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LC-MS/MS characterization of forced degradation products of zofenopril.
    Ramesh T; Nageswara Rao P; Nageswara Rao R
    J Pharm Biomed Anal; 2014 Jan; 88():609-16. PubMed ID: 24211724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LC-MS/MS studies of ritonavir and its forced degradation products.
    Rao RN; Ramachandra B; Vali RM; Raju SS
    J Pharm Biomed Anal; 2010 Dec; 53(4):833-42. PubMed ID: 20619992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and characterization of major degradation products of Eprinomectin drug substance including degradation pathways using LC-HRMS and NMR.
    Adhikari S; Rustum AM
    J Pharm Biomed Anal; 2022 Jun; 215():114767. PubMed ID: 35447491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive study on degradation profile of firocoxib and structural elucidation of its key degradation products.
    Adhikari S; Tian J; Rustum AM
    J Pharm Biomed Anal; 2023 Feb; 224():115192. PubMed ID: 36463770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of stress degradation products of amodiaquine dihydrochloride by liquid chromatography with high-resolution mass spectrometry and prediction of their properties by using ADMET Predictor™.
    Dhiman V; Singh DK; Ladumor MK; Singh S
    J Sep Sci; 2017 Dec; 40(23):4530-4540. PubMed ID: 28985017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of stress degradation products of duloxetine hydrochloride employing LC-UV/PDA and LC-MS/TOF studies.
    Chadha R; Bali A; Bansal G
    J Pharm Biomed Anal; 2016 Mar; 121():39-55. PubMed ID: 26775018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment of validated stability indicating purity method based on the stress degradation behavior of gonadotropin-releasing hormone antagonist (ganirelix) in an injectable formulation using HPLC and LC-MS-QTOF.
    Ummiti K; Shanmukha Kumar JV
    Eur J Mass Spectrom (Chichester); 2021 Apr; 27(2-4):126-140. PubMed ID: 33823624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.